Bioleaders Corporation (142760) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.041x

Based on the latest financial reports, Bioleaders Corporation (142760) has a cash flow conversion efficiency ratio of -0.041x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.26 Billion ≈ $-855.71K USD) by net assets (₩30.57 Billion ≈ $20.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 142760 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Bioleaders Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Bioleaders Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioleaders Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioleaders Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
BR.SCH.ED.HLD.SP.ADR CL.A F:BSK0	N/A
Indbank Merchant Banking Services Limited NSE:INDBANK	-0.032x
Enzo Biochem Inc NYSE:ENZ	-0.074x
Genenta Science SpA ADR NASDAQ:GNTA	-0.077x
Royal Prima PT JK:PRIM	0.002x
Carboclor BA:CARC	0.037x
US Copper Corp V:USCU	-0.153x
Curis Inc NASDAQ:CRIS	-0.708x

Annual Cash Flow Conversion Efficiency for Bioleaders Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bioleaders Corporation from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 142760 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩30.57 Billion ≈ $20.71 Million	₩-5.97 Billion ≈ $-4.05 Million	-0.195x	-1352.26%
2024-12-31	₩37.31 Billion ≈ $25.28 Million	₩-501.75 Million ≈ $-340.03K	-0.013x	-107.80%
2023-12-31	₩35.79 Billion ≈ $24.26 Million	₩6.18 Billion ≈ $4.18 Million	0.173x	+118.16%
2022-12-31	₩21.69 Billion ≈ $14.70 Million	₩-20.60 Billion ≈ $-13.96 Million	-0.950x	-751.07%
2021-12-31	₩45.11 Billion ≈ $30.57 Million	₩-5.04 Billion ≈ $-3.41 Million	-0.112x	+37.04%
2020-12-31	₩30.60 Billion ≈ $20.74 Million	₩-5.43 Billion ≈ $-3.68 Million	-0.177x	-92.34%
2019-12-31	₩23.82 Billion ≈ $16.14 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.092x	+75.30%
2018-12-31	₩23.50 Billion ≈ $15.92 Million	₩-8.77 Billion ≈ $-5.94 Million	-0.373x	-53.95%
2017-12-31	₩35.17 Billion ≈ $23.83 Million	₩-8.53 Billion ≈ $-5.78 Million	-0.242x	+45.00%
2016-12-31	₩17.46 Billion ≈ $11.83 Million	₩-7.70 Billion ≈ $-5.22 Million	-0.441x	+49.32%
2015-12-31	₩5.55 Billion ≈ $3.76 Million	₩-4.83 Billion ≈ $-3.27 Million	-0.870x	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$16.44 Million

₩24.25 Billion KRW

Market Cap Rank

#25738 Global

#1876 in Korea

Share Price

₩621.00

Change (1 day)

-1.11%

52-Week Range

₩606.00 - ₩2170.00

All Time High

₩24990.00